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Supplementary Figure 1. Antibodies and siRNA against MIDEAS and DNTTIP1 are specific.
a Schematic of MIDEAS and DNTTIP1 protein domain organisation. The antigenic region for antibody
binding and target sequence for siRNA are shown.
b Confocal images of U2OS cells transfected with plasmids coding either GFP, GFP-MIDEAS, mCherry or
mCherry-DNTTIP1 and dual stained with either GFP (green)/MIDEAS (magenta) or mCherry (magenta)/
DNTTIP1 (green). DNA (blue) was visualised with Hoechst 33258 (Scale: 25 µm). (Representative image of n=2
independent experiments)
c Western blot for GFP, MIDEAS (MID), mCherry, DNTTIP1 (DNT) and Tubulin from lysates prepared from
U2OS cells transfected with plasmids as in panel b. (n=1)
d Confocal images of PFA fixed U2OS cells following treatment with siRNA for 72 h targeting MIDEAS (top)
and DNTTIP1 (bottom). Cells were stained for either MIDEAS or DNTTIP1. DNA was visualised with
Hoechst 33258 (scale: 25 µm). (Representative image. Nuclear staining intensity was measured using FĲI
of a minimum of 300 cells across 3 independent experiments)
e Western blot for FLAG epitope from cells that had screened postive for successful CRISPR of the FLAG
epitope at the C-terminus of the MIDEAS gene in mouse ES cells. Clones in red show FLAG epitope at correct
MW for MIDEAS-FLAG protein. (n=1)
f Western blot for HDAC1, HDAC2, DNTTIP1 and FLAG following Co-IP using a FLAG antibody from CRISPR
MIDEAS-FLAG mES cell lysates. (n=1) Source data are provided in the Source data file.
PI (PE-A)
E
ve
nt
co
un
t
E
ve
nt
co
un
t
E
ve
nt
co
un
t
E
ve
nt
co
un
t
E
ve
nt
co
un
t
E
ve
nt
co
un
t
PI (PE-A) PI (PE-A)
PI (PE-A) PI (PE-A) PI (PE-A)
0 200 400 600 800 1000 0 200 400 600 800 1000 0 200 400 600 800 1000
0 200 400 600 800 1000 0 200 400 600 800 1000 0 200 400 600 800 1000
0
80
160
240
320
400
0
60
120
180
240
300
0
200
400
600
800
1000
0
200
400
600
800
0
70
140
210
280
350
0
60
120
180
240
300
Asynchronous G2/M M
G1 S (1) S (2)
G1
S
G2/M G1
S
G2/M G1
S
G2/M
G1
S
G2/M G1
S
G2/M G1
S
G2/M
G1 - 34.98%
S - 36.54%
G2/M - 29.24%
G1 - 2.91%
S - 11.77%
G2/M - 85.62%
G1 - 0.55%
S - 4.88%
G2/M - 94.90%
G1 - 84.54%
S - 2.06%
G2/M - 13.45%
G1 - 14.90%
S - 80.99%
G2/M - 4.75%
G1 - 9.80%
S - 77.30%
G2/M - 13.85%
Asynchronous G2/MG1/S
G1 G1 G1
S S S
G2/M G2/M G2/ME
ve
nt
co
un
t
E
ve
nt
co
un
t
E
ve
nt
co
un
t
PI (PE-A) PI (PE-A) PI (PE-A)
0
400
800
1200
1600
2000
0
300
600
900
1200
1500
G1 - 59.48%
S - 12.35%
G2/M - 27.05%
G1 - 46.58%
S - 31.96%
G2/M - 17.67%
G1 - 13.70%
S - 7.77%
G2/M - 76.74%
-1771980 105 106 107 -1771980 105 106 107 -1771980 105 106 107
0
600
1200
1800
2400
3000
PI (PE-A)
0 200 400 600 800 1000
PI (PE-A)
0 200 400 600 800 1000
PI (PE-A)
0 200 400 600 800 1000
PI (PE-A)
0 200 400 600 800 1000
PI (PE-A)
0 200 400 600 800 1000
PI (PE-A)
0 200 400 600 800 1000
PI (PE-A)
0 200 400 600 800 1000
PI (PE-A)
0 200 400 600 800 1000
PI (PE-A)
0 200 400 600 800 1000
PI (PE-A)
0 200 400 600 800 1000
PI (PE-A)
0 200 400 600 800 1000
0
50
100
150
200
250
E
ve
nt
co
un
t
0
200
400
600
800
0
20
40
60
80
100
120
140
E
ve
nt
co
un
t
E
ve
nt
co
un
t
E
ve
nt
co
un
t
0
200
400
600
800
1000
E
ve
nt
co
un
t
0
80
160
240
320
400
E
ve
nt
co
un
t
0
60
120
180
240
300
0
50
100
150
200
250
E
ve
nt
co
un
t
0
50
100
150
200
250
E
ve
nt
co
un
t
0
50
100
150
200
250
E
ve
nt
co
un
t
E
ve
nt
co
un
t
0
80
160
240
320
400
0
100
200
300
400
500
600
E
ve
nt
co
un
t
Asynchronous 14h CDKi 0h (+ 2h nocodazole)
2h 4h 5h
6h 7h 8h
9h 10h
G1
S
G2/M G1
S
G2/M G1
S
G2/M
G1
S
G2/M G1
S
G2/M G1
S
G2/M
G1
S
G2/M G1
S
G2/M G1
S
G2/M
G1
S
G2/M G1
S
G2/M
G1 - 29.87%
S - 36.41%
G2/M - 34.50%
G1 - 1.52%
S - 2.00%
G2/M - 96.54%
G1 - 14.16%
S - 14.78%
G2/M - 71.33%
G1 - 86.15%
S - 3.51%
G2/M - 10.43%
G1 - 26.50%
S - 68.46%
G2/M - 5.88%
G1 - 12.53%
S - 72.72%
G2/M - 15.44%
G1 - 10.97%
S - 53.64%
G2/M - 36.59%
G1 - 9.60%
S - 32.07%
G2/M - 59.54%
G1 - 7.73%
S - 22.03%
G2/M - 70.95%
G1 - 7.10%
S - 13.89%
G2/M - 79.36%
G1 - 16.21%
S - 10.41%
G2/M - 73.38%
a
b
c
Supplementary Figure 2. Representative flow cytometry graphs of synchronised cells.
a Flow cytometry plots for Fig.1e. Cells were blocked for 14 h with the Cdki RO3306 (10 µM) and then further
blocked with nocodazole (30 ng/ml) for 2 h. After release from the nocodazole block, cells were harvested at
the indicated time points to capture progression through the cell cycle.
b Flow cytometry plots for Fig. 1f. Cells were synchronised as above and after release cells were harvested at
the indicated cell cycle phase and lysates used for FLAG IP.
c Flow cytometry plots for Fig. 1g-h. Asynchronous or cells blocked with aphidicolin (1.6 µg/ml) (G1/S) or
nocodazole (3.3 µg/ml) (M) for 16 h were harvested and nuclear lysates used for MIDEAS or DNTTIP1 IP’s
followed by an HDAC activity assay.
All data were analysed and plots created using FCSalyzer v0.9.15.
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Supplementary Figure 3. Effect of siRNA on MiDAC mRNA and protein expression and FLAG-DNTTIP1 rescue.
a-c qPCR analysis of MIDEAS (a), DNTTIP1 (b) and HDAC1 (c) following treatment of U2OS cells with siRNA
against MIDEAS or DNTTIP1 for 72 h. Relative expression was calculated using the ∆∆CT method relative
to the housekeeping gene B2-microglobulin and normalised to the control samples (Mean ± s.e.m, n=3 independent
experiments, *p<0.01 (a P=0.0061 for control versus MID_si1, 0.0017 for control versus MID_si2), ****p<0.0001, one-
way ANOVA with Dunnett’s post hoc test).
d Quantification of HDAC1 protein levels in U2OS cells following treatment with siRNA for 72 h
targeting MIDEAS or DNTTIP1. LaminB was detected in parallel from the same lysate sample and was used as a
reference for normalisation (Mean ± s.e.m, n=3 independent experiments).
e-g Quantification of DNTTIP1 (e) and FLAG-DNTTIP1 (f,g) protein levels in U2OS cells following treatment with siRNA
for 72 h targetting DNTTIP1. After 48 h, expression of the siRNA resistant FLAG-DNTTIP1 was induced by DOX.
Alpha-tubulin was detected in parallel from the same lysate sample and was used as a reference for normalisation
(Mean ± s.e.m, n=3 independent experiments, **p<0.01 (a p=0.0033 for control versus DNT_si2 w/o DOX, 0.002
for control versus DNT_si1 with DOX, 0.0063 for control versus DNT_si2 with DOX), ***p=0.0009, one-way ANOVA
with Holm-Sidak post hoc test).
Source data are provided in the Source data file.
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Supplementary Figure 4. CRISPR-targetted deletions in MIDEAS and DNTTIP1 and representative
genotyping.
a Organisation of MIDEAS exon and intragenic regions. CRISPR-targetted sequence is in exon 2
(ENSMUSE00000408326). Sequencing data is from first generation heterozygous mice. Agarose gel shows
representative genotyping of litters from Het x Het mates with the wildtype (top) and deletion (bottom) alleles
clearly distinguishable.
b Organisation of DNTTIP1 exon and intragenic regions. CRISPR-targetted sequence is in exon 2
(ENSMUSE00000171721). Sequencing data is from first generation heterozygous mice. Agarose gel shows
representative genotyping of litters from Het x Het mates with the wildtype (bottom) and deletion (top) alleles
clearly distinguishable.
Source data are provided in the Source data file.
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Supplementary Figure 5. Histology of mouse embryo heart and liver and MEF RNAseq pathway and GSEA.
a Quantification of embryo length from e16.5 embryos. Embryo size was calculated using FĲI by drawing a line from the
top of the embryo head to its bottom. (Mean ± s.e.m, n=7, 7, 9 (MIDEAS-del1 +/+, +/-, -/- respectively), n=10, 6, 4 (DNT-
TIP1-del1 +/+, +/-, -/- respectively), **p<0.01 (p=0.008 for +/+ versus -/-, 0.0033 for +/- versus -/-), ****p<0.0001, one- way
ANOVA with Tukey’s post hoc test).
b Comparison of DNTTIP1-del1 wildtype and homozygous embryo’s at e13.5, e15.5 and e16.5. Scale bar = 5 mm.
c Images of whole embryos stained for H&E. Overall the knockout embryos look normal in terms of limb development
compared to wildtype. (Representative images from n=2 biologically independent animals). Scale bar = 5 mm.
d Images of sections from wildtype, MIDEAS-/- and DNTTIP1-/- e16.5 embryos. Images show lack of erythrocytes in the
heart and rounded shape with an enlarged pericardium and deformed ventricle morphology in the knockout compared to
wildtype (arrows). Overall morphology of the liver and close up showing similar distribution and presence of haematopoietic
cells in both. (Representative images from n=2 biologically independent animals). Scale bar upper six panels = 500 µm.
Scale bar lower three panels = 50 µm.
e Functional classification of the overlapping, upregulated gene set using PANTHER (Protein Analysis Through Evolution-
ary Relationships) (http://www.pantherdb.org).
f GSEA comparing MIDEAS and DNTTIP1 knockout MEFs to wildtype. (NES; normalised enrichment score, calculated by
the GSEA software using default parameters (www.broad.mit.edu/gsea)).
Source data provided in the Source data file.
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Supplementary Figure 6. Characterisation of MIDEAS-del1 and DNTTIP1-del1 MEF lines.
a,b Genotyping results for wildtype and homozygous e13.5 MEFs from MIDEAS-del1 (a) and
DNTTIP1-del1 (b) embryos. (n=3 a, n=2 b, from biologically independent cells isolated from e13.5 embryos)
c Fluorescent HDAC activity assay from DNTTIP1 IP using nuclear protein lysates from wildtype and
homozygous knockout MIDEAS-del1 MEFs. (Mean ± s.e.m, n=3 biologically independent cells isolated from
e13.5 embryos, ***p=0.0003, two-tailed unpaired Student’s t-test).
d Western blot for DNTTIP1, HDAC1 and tubulin using nuclear protein lysates from wildtype and homozygous
knockout DNTTIP1-del1 MEFs. (n=2 from biologically independent cells isolated from e13.5 embryos).
e,f Proliferation over 96 h for wildtype and homozygous MEFs from MIDEAS-del1 (e) and DNTTIP1-del1 (f) lines.
Cells (0.1x106) were seeded into wells and every 24 h detached using trypsin and counted using a BioRad
automated cell counter. (Mean ± s.e.m, n=3 e, n=2 f, from biologically independent cells isolated from
e13.5 embryos).
g,h Cell cycle distribution of wildtype and homozygous knockout MIDEAS-del1 (g) and DNTTIP1-del1 (h) MEFs.
(Mean ± s.e.m, n=3 (MIDEAS-del1), n=2 (DNTTIP1-del1) from biologically independent cells isolated from
e13.5 embryos).
Source date provided in the Source data file.
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Supplementary Figure 7. Summary of the image processing procedures followed
in Relion3 for the dimer and tetramer including the DNTTIP1 DNA-binding domain
DNTTIP1(1-130), MIDEAS (717-887), HDAC1 (1-482) with 50 μM IP6, 50 μM SAHA
DNTTIP1 (1-150), MIDEAS (717-887), HDAC1 (1-482)
Dimer 167,472 particles Tetramer 151,434 particles
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Supplementary Figure 8. Summary of the image processing procedures followed
in Relion3 for the dimer and tetramer lacking the DNTTIP1 DNA-binding domain
Supplementary Figure 9. Resolution assessment for the MiDAC complexes
a Fourier Shell Correlation between the two half-maps (blue) and between the Postprocess map from
Relion and the refined model (orange) for the dimer.
b Electron density map of the Refine3D map from Relion3 coloured by resolution for the dimer.
c Angular distribution of particles for the Refine3D map of the dimer using C2 symmetry.
d Fourier Shell Correlation between the two half-maps (blue) and between the Postprocess map from
Relion and the refined model (orange) for the tetramer.
e Electron density map of the Refine3D map from Relion3 coloured by resolution for the tetramer.
f Angular distribution of particles for the Refine3D map of the tetramer using D2 symmetry.
Source data are provided in the Source data file.
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Supplementary Figure 10. Details of the MiDAC structure, maps and comparisons
a Close up of the 4.5 Å map of the tetrameric complex showing IP6.
b View of the interaction between MIDEAS and the non-polar groove in the DNTTIP1 dimerisation domain.
c Comparison of the SANT domain in MIDEAS with MTA1:HDAC1 (PDB: 5icn) and SMRT:HDAC3 (PDB: 4a69).
The ELM2 specific motif common to MIDEAS and MTA1 (but not SMRT) is highlighted.
d Close up of the interactions between the MIDEAS SANT domains in the tetramer.
e Lysine residues that are likely to mediate additonal tetrameric interactions with IP6 are highlighted. Note that density
for these was not seen in the 4.5 Å map.
f Comparison of the maps around the core of the HDAC1 enzyme in tetrameric complex with and without IP6.
g Evidence in the 4.5 Å map that the amino-terminal region of DNTTIP1 crosses over, contributing to tetrameric
interactions.
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Supplementary Figure 11. Postprocess map from Relion3 of tetramer.
30° 30° 30°
-MIDEAS 717-887
-DNTTIP1 1-130
-HDAC1 1-482
-HDAC1 1-482
-MIDEAS 717- 887
-DNTTIP1 1-150
-HDAC1 1-482
-HDAC1 1-482
Supplementary Figure 12. Analysis of MiDAC complexes with different length constructs of DNTTIP1
a Gel filtration profiles of the complex from a Superdex S-200 column with DNTTIP1 (1-150), (1-130) and (51-150)
b-d SDS-PAGE of the complexes from a Superdex S-200 column with DNTTIP1 (1-150), (1-130) and (51-150)
e SDS PAGE of the gel filtration purification from a Superdex S-200 gel filtration column of the complex
with full-length DNTTIP1 containing the DNA-binding domain.
f Electron micrograph of the complex with full-length DNTTIP1 containing the DNA-binding domain. Scale bar = 20nm.
g 2D class averages of the complex with full-length DNTTIP1 containing the DNA-binding domain.
Source data are provided in the Source data file.
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Supplementary Figure 13. Gating strategies used for flow cytomtery.
a Gating strategy to determine cell cycle distribution of ES cells presented in Fig. 1e,f.
b Gating strategy to determine cell cycle distribution of U2OS cells presented in Fig. 1g,h.
c Gating strategy to determine cell cycle distribution of MEF cells presented in Supp. Fig. 6g,h.
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Supplementary Table 1. Genotyping of mouse embryos and litters from MIDEAS +/- or DNTTIP1 +/- mates
e17.5 4 6 0 10
DAVID Panther 
Wnt 
signalling 
Adhesion Axon 
Guidance 
Angiogenesis Wnt / 
Cadherin 
signalling 
Axon 
guidance 
EGF/FGF Angiogenesis 
Fzd4 Atplb2 Gli2 Angpt2 Fzd4 Pik3r1 Shc3 Pik3r1 
Fzd9 Ephb4 Apbb1 Tek Fzd9 Dcc Mras Angpt2 
Frzb Fat3 Ank3 Vash2 Frzb Ntn1 Map2k6 Sfrp1 
Wnt11 Frem1 Boc  Wnt11 Ntn3 Map3k5 Frzb 
Wnt2 Adam23 Bmp7  Wnt2   Wnt2 
Amer1 Ackr3 Cdh4  Celsr1   Tek 
Dixdc1 Boc Dcc  Pcdh10    
CDK14 Cdh4 Dix5  Pcdh18    
Lgr4 Cdh6 Efna3  Pcdhb19    
Lrp4 Cdh8 Efna5  Plcb1    
Nkd1 Cdh26 Ntn1  Pygo1    
Pygo1 Celsr1 Ntn3  Arrb1    
Ror1 Col6a6 Sema5a  Smad9    
Sfrpl1 Cntn1   Dchs1    
Sfrpl4 Dchs1   Cdh4    
Tcf7l1 Emilin2   Cdh6    
 Fbtn7   Cdh8    
 Kit1   Sfrp1    
 Nid2   Sfrp4    
 PlcBl2       
 Pcdh10       
 Pcdh18       
 Span2       
        
        
        
        
 
Supplementary Table 2. Upregulated genes identified to play roles in development 
 
OverlappingDNTTIP1MIDEAS
Down Up Down Up Down Up
Septin 4
Septin 3
Septin 6
Ubiquitin specific
peptidase 29
CDKi 1C
MAP, RP/EB fmily,
member 2
cDNA sequence
BC034090
Tubulin alpha 4a
Septin 4
Septin 3
Septin 6
Ubiquitin specific
peptidase 29
CDKi 1C
MAP, RP/EB fmily,
member 2
Septin 4
Septin 3
Septin 6
Ubiquitin specific
peptidase 29
CDKi 1C
MAP, RP/EB fmily,
member 2
cDNA sequence
BC034090
Tubulin alpha 4a
cDNA sequence
BC034090
Tubulin alpha 4a
Timeless
Cell Division Cycle 6
Wee1
DNA Topoisomease
II alpha
Anillin
Rhotekin 2
F-box only protein 5
Cyclin E2
Rad21
Tubulin epsilon 1
Cyclin D1
non-SMC condensin
1 complex
SPC25
MT associated
protein (MAP) 10
IL1R associated
kinase 3
Tubulin delta 1
Pard6b
Actin, gamma-
enteric
Actin, alpha 1
Polo-like kinase 2
Myosin VC
Myosin 1C
Tubulin alpha 4a
Tubulin alpha 8
Tubulin beta 6
IL1R associated
kinase 1
DNA excision repair
protein ERCC1
Supplementary Table 3. Cell cycle associated genes up and down regulated in knockouts
Supplementary Table 4. GSEA for spindle organisation showing enrichment in wildtype samples
Gene Symbol Gene title Rank in gene list Rank metric score Running ES Core enrichment
296
1855
2224
3471
3611
4235
4248
4274
4723
4865
5102
5592
5810
5815
7741
11397
12327
12592
13226
Yes
No
Yes
No
Yes
No
Yes
No
Yes
No
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
CHMP4C
PARP3
CHMP3
CHMP18
PSRC1
RNF4
CHMP5
CHMP1A
TPR
PDCD6IP
CHMP2A
SENP6
BORA
CHMP4B
VPS4B
PKD1
TPX2
PLK1
CHMP2B
0.93
0.43
0.38
0.28
0.27
0.22
0.22
0.19
0.18
0.17
0.14
0.13
0.13
0.035
-0.06
-0.12
-0.14
-0.19
0.22
0.19
0.20
0.27
0.26
0.32
0.33
0.38
0.43
0.45
0.48
0.51
0.51
0.53
0.56
0.46
0.28
0.25
0.27
0.28
Chromatin modifying
protein 4C
Chromatin modifying
protein 18
Chromatin modifying
protein 5
Chromatin modifying
protein 1A
Chromatin modifying
protein 2A
Chromatin modifying
protein 4B
Chromatin modifying
protein 2B
Proline/serine-rich
coiled-coil 1
Ring finger protein 4
Programmed cell
death 6 interacting protein
SUMO1/sentrin specific
peptidase 6
Polo-like kinase 1
Polycystic kidney
disease 1
Vacuolar protein sorting
4 homolog B
Translocated promotoer
region
Poly (ADP-ribose)
polymerase family member 3
TPX2, microtubule-
associated, homolog
Chromatin modifying
protein 3
null
 
 Dimer 
(EMD-11041) 
(PDB 6Z2J) 
Tetramer 
(EMD-11042) 
(PDB 6Z2K) 
Data collection and processing   
Magnification    75,000 75,000 
Voltage (kV) 300 300 
Electron exposure (e–/Å2) 35.0 35.0 
Defocus range (μm) -0.5 -0.5 
Pixel size (Å) 1.08 1.08 
Symmetry imposed C2 D2 
Initial particle images (no.) 337,840 178,285 
Final  particle images (no.) 126,484 63,222 
Map resolution (Å) 
    FSC threshold 
4.0 
0.143 
4.5 
0.143 
Map resolution range (Å) 4.0-5.8 4.5-5.5 
   
Refinement   
Initial model used (PDB code) 5ICN, 4D6K 5ICN, 4D6K 
Model resolution (Å) 
    FSC threshold 
3.90 
0.143 
4.37 
0.143 
Model resolution range (Å)   
Map sharpening B factor (Å2) -70 -127 
Model composition 
    Non-hydrogen atoms 
    Protein residues 
    Ligands 
 
9,613 
1,186 
8 
 
19,298 
2,373 
16 
B factors (Å2) 
    Protein 
    Ligand 
 
81.4 
91.4 
 
239.6 
234.1 
R.m.s. deviations 
    Bond lengths (Å) 
    Bond angles (°) 
 
0.003 
0.743 
 
0.004 
0.824 
 Validation 
    MolProbity score 
    Clashscore 
    Poor rotamers (%)    
 
1.44 
1.91 
0.2 
 
1.57 
2.56 
0.15 
 Ramachandran plot 
    Favored (%) 
    Allowed (%) 
    Disallowed (%) 
 
92.12 
7.88 
0 
 
90.84 
8.95 
0.21 
   
 
Supplementary Table 5: Cryo-EM data collection, refinement and validation statistics 
 
Construct  
Untagged  
DNTTIP1 1-329 
Forward 
ACCCAAGCTTGGTACCATGGGAGCCACTGGCGACGCC TDIF1_LF_4 
Reverse  
GACGGAGCTCGAATTTCAGGTCTGTGGAGGTGCTTCAAC TDIF1_LF_3 
Untagged 
DNTTIP1 1-150 
Forward 
ACCCAAGCTTGGTACCATGGGAGCCACTGGCGACGCC TDIF1_LF_4 
Reverse 
GACGGAGCTCGAATTTCAACGGCCACGCTTTATTCCTGG TDIF1_LF_7 
Untagged 
DNTTIP1 51-150 
Forward 
ACCCAAGCTTGGTACCATGGGCCGCCGCTCACAGATGACA TDIF1_LF_14 
Reverse 
GACGGAGCTCGAATTTCAACGGCCACGCTTTATTCCTGG TDIF1_LF_7 
Untagged 
DNTTIP1 1-130 
Forward 
ACCCAAGCTTGGTACCATGGGAGCCACTGGCGACGCC TDIF1_LF_4 
Reverse 
GACGGAGCTCGAATTTCATGAAAAGAGCAGTTTAGCCTG TDIF1_LF_15 
Untagged  
HDAC1 1-482 
Forward 
ACCCAAGCTTGGTACCATGGCGCAGACGCAGGGCACC HDAC1_CM_4 
Reverse 
GACGGAGCTCGAATTTTAGGCCAACTTGACCTCCTCCTT HDAC1_CM_3 
Flag tagged  
MIDEAS 628-887 
Forward 
GTATTTTCAGGGCGCCACCCCATACCAGAGCCACCTG MIDEAS_LF_13 
Reverse 
GACGGAGCTCGAATTTTAGGTTAGAGTCCCATTGCGGCC MIDEAS_LF_9 
Flag tagged  
MIDEAS 717-887 
Forward 
GTATTTTCAGGGCGCCGTGAGCATCGAGCCACGGATC MIDEAS_LF_15 
Reverse 
GACGGAGCTCGAATTTTAGGTTAGAGTCCCATTGCGGCC MIDEAS_LF_9 
GFP tagged 
MIDEAS 1-1019 
Forward 
TCCGGACTCAGATCTATGAACCTCCAGGCCCAGCCC MIDEAS_RT_1 
Reverse 
GTCGACTGCAGAATTTTATGAAAAAGGTAGTGCCCTTCG MIDEAS_RT_2 
mCherry tagged 
DNTTIP1 1-329 
Forward  
TCCGGACTCAGATCTATGGGAGCCACTGGCGACGCC TDIF1_RT_1 
Reverse 
GTCGACTGCAGAATTTCAGGTCTGTGGAGGTGCTTC TDIF_RT_2 
PiggyBac 
FLAG tagged 
DNTTIP1 1-329 
Forward 
GTCGAGTTAATTTGTTAACCACCATGGATTACAAGGATCATGACATTGACTACAAA 
GACGATGACGACAAGGGAGCCACTGGCGACGCC DNTTIP1_RT_13 
Reverse 
TGGTTAGCAGAGGGTTAACTCAGGTCTGTGGAGGTGCTTC DNTTIP1_RT_14 
Silent mutation for 
DNT_si1 resistance 
Forward  
CTACATCAAGCACCCACATCTCTTTAAATATGCAGCTGACCCCCAG DNTTIP1_RT_9 
Reverse  
CTGGGGGTCAGCTGCATATTTAAAGAGATGTGGGTGCTTGATGTAG DNTTIP1_RT_10 
Silent mutation for 
DNT_si2 resistance 
Forward 
GCTGGTTCTTACGAACCCCTGGAACATCATGATAAAGCACCGGCAG DNTTIP1_RT_11 
Reverse  
CTGCCGGTGCTTTATCATGATGTTCCAGGGGTTCGTAAGAACCAGC DNTTIP1_RT_12 
 
 
 
Supplementary Table 6. Oligonucleotides used for cloning 
